Company Profile for InNexus Biotechnology Inc.InNexus is an innovative antibody-driven drug development company that has developed two technology platforms, SuperAntibody(TM) and TransMAbs(TM), which improve the potency potency /po·ten·cy/ (po´ten-se) 1. the ability of the male to perform coitus. 2. the relationship between the therapeutic effect of a drug and the dose necessary to achieve that effect. 3. of existing antibody products while opening new markets and disease applications. Both platforms utilize unique, novel and patented methods and technologies of InNexus. InNexus is headquartered in Scottsdale, Ariz., on the campus of The Mayo Clinic Mayo Clinic: see Mayo, Charles Horace. Mayo Clinic voluntary association of more than 500 physicians in Rochester, Minnesota. [Am. Hist.: EB, 11: 723] See : Medicine and has its own in-house developmental facilities. These development facilities provide validation See validate. validation - The stage in the software life-cycle at the end of the development process where software is evaluated to ensure that it complies with the requirements. of protein and peptide peptide, organic compound composed of amino acids linked together chemically by peptide bonds. The peptide bond always involves a single covalent link between the α-carboxyl (oxygen-bearing carbon) of one amino acid and the amino nitrogen of a second amino acid. discoveries, enabling InNexus (and its strategic partners) to advance novel drug therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. and diagnostics. To learn more about InNexus please visit www.innexusbiotech.com.
Company: InNexus Biotechnology Inc.
Headquarters Address: 13208 East Shea Blvd., Ste. 200
The Mayo Clinic MCCRB Building
Scottsdale, Arizona 85259
Main Telephone: 877-990-8382
Website: www.innexusbiotech.com
Ticker: IXS(TSX);IXSBF(OTCBB)
Type of Organization: Public
Industry: Health: Biotechnology
Key Executives: CEO: Charles Morgan
COO: Jeff Morhet
VP Corporate Development
Contact: Gail Thurston
Phone: 877-990-8382
Email: gthurston@innexusbiotech.com
|
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion